DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma
- PMID: 17292327
- DOI: 10.1016/j.bbrc.2007.01.121
DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma
Abstract
DLC-1 (deleted in liver cancer-1) is a tumor suppressor gene for hepatocellular carcinoma and other cancers. To characterize its functions, we constructed recombinant adenovirus encoding the wild-type DLC-1 and examined its effects on behaviors of a hepatocellular carcinoma cell line (SNU-368), which does not express DLC-1. Here, we found that restoration of DLC-1 expression in the SNU-368 cells caused an inhibition of cell proliferation with an increase of a subG1 population. Furthermore, DLC-1 overexpression induced disassembly of stress fibers and extensive membrane protrusions around cells on laminin-1. DLC-1 overexpression also inhibited cell migration and dephosphorylated focal adhesion proteins such as focal adhesion kinase (FAK), Cas (p130Cas; Crk-associated substrate), and paxillin. These observations suggest that DLC-1 plays important roles in signal transduction pathway regulating cell proliferation, cell morphology, and cell migration by affecting Rho family GTPases and focal adhesion proteins.
Similar articles
-
Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.Cancer Lett. 2009 Sep 28;283(1):59-67. doi: 10.1016/j.canlet.2009.03.025. Epub 2009 Apr 19. Cancer Lett. 2009. PMID: 19380190
-
Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.Cancer Res. 2005 Oct 1;65(19):8861-8. doi: 10.1158/0008-5472.CAN-05-1318. Cancer Res. 2005. PMID: 16204057
-
[Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma].Zhonghua Gan Zang Bing Za Zhi. 2005 Jun;13(6):428-31. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15975276 Chinese.
-
The Role of Tumor Suppressor DLC-1: Far From Clear.Anticancer Agents Med Chem. 2017;17(7):896-901. doi: 10.2174/1871520616666160907142754. Anticancer Agents Med Chem. 2017. PMID: 27604574 Review.
-
DLC-1:a Rho GTPase-activating protein and tumour suppressor.J Cell Mol Med. 2007 Sep-Oct;11(5):1185-207. doi: 10.1111/j.1582-4934.2007.00098.x. J Cell Mol Med. 2007. PMID: 17979893 Free PMC article. Review.
Cited by
-
Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression.J Cell Mol Med. 2020 Sep;24(18):10648-10662. doi: 10.1111/jcmm.15683. Epub 2020 Jul 28. J Cell Mol Med. 2020. PMID: 32725802 Free PMC article.
-
Pilot study: alteration of deleted in liver cancer1 and phosphorylated focal adhesion kinase Y397 cytoplasmic expression and the prognostic value in advanced epithelial ovarian carcinoma.Int J Mol Sci. 2011;12(12):8489-501. doi: 10.3390/ijms12128489. Epub 2011 Nov 29. Int J Mol Sci. 2011. PMID: 22272086 Free PMC article.
-
Detection and Clinical Significance of DLC1 Gene Methylation in Serum DNA from Colorectal Cancer Patients.Chin J Cancer Res. 2011 Dec;23(4):283-7. doi: 10.1007/s11670-011-0283-0. Chin J Cancer Res. 2011. PMID: 23359753 Free PMC article.
-
Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver.Int J Biochem Cell Biol. 2008;40(5):843-7. doi: 10.1016/j.biocel.2007.04.008. Epub 2007 Apr 20. Int J Biochem Cell Biol. 2008. PMID: 17521951 Free PMC article. Review.
-
Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.PLoS One. 2009;4(5):e5572. doi: 10.1371/journal.pone.0005572. Epub 2009 May 15. PLoS One. 2009. PMID: 19440389 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous